Next Article in Journal
Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail
Next Article in Special Issue
A Perspective on Microneedle-Based Drug Delivery and Diagnostics in Paediatrics
Previous Article in Journal
Precision Oncology—The Quest for Evidence
Previous Article in Special Issue
Omics Meeting Onics: Towards the Next Generation of Spectroscopic-Based Technologies in Personalized Medicine
Open AccessPerspective

Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology

International Iberian Nanotechnology Laboratory, 4715-330 Braga, Portugal
*
Authors to whom correspondence should be addressed.
J. Pers. Med. 2019, 9(3), 44; https://doi.org/10.3390/jpm9030044
Received: 4 June 2019 / Revised: 28 August 2019 / Accepted: 4 September 2019 / Published: 12 September 2019
Cancer is a leading cause of death worldwide and therefore one of the most important public health concerns. In this contribution, we discuss recent key enabling technological innovations (and their challenges), including biomarker-based technologies, that potentially allow for decentralization (e.g., self-monitoring) with the increasing availability of point-of-care technologies in the near future. These technological innovations are moving the field one step closer toward personalized oncology. View Full-Text
Keywords: personalized oncology; technological innovations personalized oncology; technological innovations
Show Figures

Figure 1

MDPI and ACS Style

Cruz, A.; Peng, W.K. Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology. J. Pers. Med. 2019, 9, 44.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop